2 of 5label trials that showed efficacy for fine wrinkles
Evidence · Skin
How deep is the trial record for tretinoin, and what do the FDA labels say
PubMed holds 210 randomized-trial papers on topical tretinoin. Its own wrinkle label says it does not reverse photoaging, and its acne label has a different job again.
On 30 October 2026, PubMed held 210 randomized-trial papers on topical tretinoin. On 3 November 2026, the Renova label said the cream does not eliminate wrinkles, repair sun-damaged skin or reverse photoaging, and that only 2 of its 5 trials showed efficacy for fine wrinkles.
PubMed counts read 30 October 2026; the Renova and Retin-A labels, MedlinePlus and the review abstracts read 3 November 2026.
The short version
210trial-typed papersPubMed, tretinoin query
2 of 5label trials showed efficacyfine wrinkles only, per the Renova label
32%severe irritation or a pauseRenova label studies, 339 patients
Tretinoin: claims against the recordwhat gets said, and what the record shows, read 3 November 2026
They sayTretinoin reverses sun damage and aging.
Hype is running ahead
The Renova label says the cream does not eliminate wrinkles, repair sun-damaged skin, reverse photoaging or restore younger skin, and that it has not shown an effect on coarse wrinkles, mottled pigmentation or other signs of chronic sun exposure. See the receipt
They sayIt is just a face cream, so there is nothing to worry about.
Not that simple
The label calls it a dermal irritant, reports severe irritation in 32% of study patients, says to avoid the sun, and says not to use it in pregnancy. See the receipt
They sayHundreds of trials prove it works.
Depth, not effect
A deep record is depth, not effect. In the Renova label, 2 of 5 trials demonstrated efficacy for fine wrinkles, and a darkly pigmented subgroup did better on the vehicle cream. See the receipt
What do the labels and NIH say it is for?
The Renova label says the cream is an adjunct for the mitigation of fine facial wrinkles in people who also use a comprehensive skin care and sunlight avoidance program.[1] The Retin-A label says it is indicated for acne vulgaris, and that safety and efficacy of long-term use for other disorders are not established.[2]
Read the reasoning
MedlinePlus says tretinoin is used to treat acne and to reduce fine wrinkles, and that it does not remove wrinkles or repair sun-damaged skin.[3] This page covers topical tretinoin only, and the Copium Meter's hype-versus-trials view is on the tretinoin page. Oral tretinoin is a different drug with a boxed warning and is used for a leukemia.
Papers typed as randomized controlled trials, and as systematic reviews or meta-analyses, for the evidence ladder's tretinoin query, read 30 October 2026. Counts of tagged papers, not effect or quality.
That is 999 papers in all, so about 21 percent are trial-typed, and the query mixes acne and photoaging work.
A 2024 systematic review of 25 studies comparing tretinoin with other topical products called its comparators variable (better in 7, equivalent in 13, worse in 3) and said most such studies were of poor quality or showed bias.[6]
To read the newest label for any prescription drug name yourself, use the Label Checker, and see the evidence ladder for how this compares with other topics, though a count says nothing about who was studied or how large any effect was.
What did the label's own trials show for wrinkles?
The Renova label describes five trials, four multi-center and one single-center, with 324 evaluable patients on the cream and 332 on the vehicle, run for 24 weeks alongside a sun-protection program.[1] It says two of the five demonstrated efficacy for fine facial wrinkling, and that no two of the five demonstrated efficacy for coarse wrinkling, mottled pigmentation, roughness or laxity.
From the Renova label's pooled table for fine wrinkling (279 treated and 280 vehicle subjects, Fitzpatrick skin types I to III). Everyone also followed a sun-protection program. "Any improvement" is this page's sum of the label's minimal, mild and moderate rows, so rounding can shift it by a point. The vehicle is the same cream without tretinoin.
In lightly pigmented subjects, fine wrinkling was improved in about 60% on the cream and 39% on the vehicle, with the sun-protection program applied to both.
In the single study of darkly pigmented subjects (107 people), minimal or mild improvement occurred in 43% on the vehicle and 29% on tretinoin, and the label says this may reflect the small size of the study.
The label says patients with visible actinic keratosis or a history of skin cancer were excluded, so effectiveness and safety in them are not known.
The label's single-center study of 107 mostly African-American subjects with Fitzpatrick skin types IV to VI. The label says the finding may reflect the small size of the study.
What do the labels say about safety?
The Renova label calls the cream a dermal irritant, and says almost all patients in its studies reported at least one local reaction such as peeling, dry skin, burning, stinging, redness or itching.[1] The Retin-A label says reactions in sensitive skin can include excessive redness, swelling, blistering or crusting, and that all of its adverse effects have been reversible after stopping.[2]
As the Renova label reports it for its double-blind, vehicle-controlled studies. The control bar is drawn at 1 percent and the label says less than 1 percent.
In the Renova studies, 32% of patients had irritation that was severe, led to a pause, or led to a mild steroid, about 4% stopped, and about 2% of postmarketing reports for the other Renova strength concerned lighter or darker skin patches.
The label says to avoid or minimize sunlight, to use sunscreen and protective clothing (see the sunscreen safety guide), and not to use the cream with photosensitizing drugs such as thiazides, tetracyclines or fluoroquinolones. It says people with a sunburn should wait until healed, and to use caution on eczematous skin.
The label says safety and efficacy of daily use beyond 52 weeks have not been established, and it describes atypical changes in skin cells and more elastosis in some patients using the other Renova strength for longer than 48 weeks, with unknown significance.
Safety and effectiveness under 18 are not established, and the label says use may be postponed in nursing mothers.
Questions the labels raise
1. Is it for acne or for fine wrinkles? The two labels are for different uses.
2. Are you pregnant or trying to be? The Renova label says not to use it.
3. Do you take a medicine that makes skin sun-sensitive? The label names several.
4. Eczema, sunburn or a skin cancer history? The label flags all three.
5. Planning years of use? The label says safety past 52 weeks has not been established.
What does the Renova label say about pregnancy?
The label says Renova should not be used during pregnancy and that there are no adequate and well-controlled studies in pregnant women.[1] It reports animal findings, including malformations in animals given oral tretinoin and equivocal results for topical tretinoin.
It says thirty human cases of congenital malformations were reported over two decades of use of another topical tretinoin product, Retin-A, and that five described a rare forebrain defect called holoprosencephaly.
It also says no definite pattern and no causal association was established, and that the significance of the reports for risk to the fetus is not known.
MedlinePlus tells people to tell their doctor if they are pregnant, plan to become pregnant or are breastfeeding.[3]
What do the safety reviews say?
A 2011 systematic review of 20 studies found that 27.9% of people on topical tretinoin reported at least one adverse event outside the skin, and that the majority were transient and judged not related to the drug.[7] Its abstract says there was no clear evidence of a link before a recent report of excess deaths in a clinical trial, and notes that many included trials reported mostly local reactions.
This page did not read that trial or either full paper. The 2024 review said tretinoin's poor tolerability often limits its use.[6]
What else is registered?
ClinicalTrials.gov lists 174 interventional studies matching tretinoin with acne, photoaging or skin.[8] A registration is a plan on file, and we have not assessed any of them.
Interventional studies matching tretinoin with acne, photoaging or skin, read 3 November 2026. A registration is a plan on file, not a finished or positive result, and we have not assessed any of them.The first box is narrower than the marketing around it. The last two are where a dermatologist earns the fee.
How should you use this page?
If you are weighing an anti-aging claimLabel: fine wrinkles, modestlyThe label's own trials support fine wrinkles only, and the label says it does not reverse photoaging. A deep trial count is not the same as a big effect.
If you are weighing the trade-offsIrritation, sun and pregnancy are the headline itemsThe label reports severe irritation in about a third of study patients, asks for sun protection, and says not to use it in pregnancy.
If you want to use itIt is a prescription product: ask a clinicianThis page gives no amounts or instructions and no way to source it. Whether it suits your skin and your situation is a question for a dermatologist.
How this page was built
Method
The Renova and Retin-A labels were read through openFDA in the sections named above (indications, contraindications, warnings, precautions, adverse reactions, pregnancy, pediatric and geriatric use, and the clinical studies text and table), and each links to the label on DailyMed. MedlinePlus was read in full, and the two reviews were read as PubMed abstracts only.
PubMed counts are the evidence ladder's own, read 30 October 2026, and ClinicalTrials.gov was read 3 November 2026.
Limits: openFDA's copy of a label can be older than DailyMed's, the full review papers were not read, "any improvement" is this page's sum of three label rows, and no amount, strength or application instruction is given. Queries are broad and the counts show depth of record only (our grading rules are on the methodology page, and every comparison lives on the ladder hub). Nothing here is medical advice.
The exact query
PubMed: tretinoin[tiab] AND (skin[tiab] OR acne[tiab] OR photoaging[tiab])
ClinicalTrials.gov: tretinoin AND (acne OR photoaging OR skin), interventional studies
References
abcd Bausch Health US. Renova (tretinoin cream) prescribing information, version 14, effective 24 February 2026. Sections read as held by openFDA; the full label is on DailyMed. dailymed.nlm.nih.gov, read 3 November 2026.
ab Bausch Health US. Retin-A (tretinoin) prescribing information, version 15, effective 17 May 2024. Sections read as held by openFDA; the full label is on DailyMed. dailymed.nlm.nih.gov, read 3 November 2026.
ab MedlinePlus, National Library of Medicine. Tretinoin Topical (revised 15 December 2025). medlineplus.gov, read 3 November 2026.
↑ PubMed search on topical tretinoin with publication-type filters (the evidence ladder query, printed in the method section). pubmed.ncbi.nlm.nih.gov, read 30 October 2026.
↑ National Library of Medicine. MeSH publication type: Randomized Controlled Trial. ncbi.nlm.nih.gov.
ab Siddiqui Z, et al. Comparing tretinoin to other topical therapies in the treatment of skin photoaging: a systematic review. Am J Clin Dermatol 2024;25:873-890. Abstract read; full paper not read. pubmed.ncbi.nlm.nih.gov, read 3 November 2026.
↑ Shapiro J, et al. Use of topical tretinoin and the development of noncutaneous adverse events: evidence from a systematic review of the literature. J Am Acad Dermatol 2011;65:1194-1201. Abstract read; full paper not read. pubmed.ncbi.nlm.nih.gov, read 3 November 2026.
↑ ClinicalTrials.gov interventional studies matching tretinoin with acne, photoaging or skin, read 3 November 2026. clinicaltrials.gov, read 3 November 2026.
FAQ
How many randomized trials are there on topical tretinoin?
PubMed held 210 papers typed as randomized controlled trials and 36 systematic reviews or meta-analyses for the evidence ladder's tretinoin query on 30 October 2026.
Does tretinoin reverse sun damage?
The Renova label says the cream does not eliminate wrinkles, repair sun-damaged skin, reverse photoaging or restore younger skin. It says only 2 of its 5 trials demonstrated efficacy, for fine wrinkling.
What are the side effects of topical tretinoin?
The Renova label reports peeling, dry skin, burning, stinging, redness and itching in almost all study patients, with severe irritation, a pause or a mild steroid in 32%. It asks for sun protection and cautions on eczema and sunburn.
Can you use tretinoin when pregnant?
The Renova label says it should not be used during pregnancy. It reports animal findings and 30 human case reports of malformations with another topical tretinoin product, with no causal association established. Ask a clinician.
Is tretinoin the same as Retin-A and Renova?
Tretinoin is the active ingredient. The Retin-A label is for acne vulgaris and the Renova label is for fine facial wrinkles. Oral tretinoin is a different drug used for a leukemia.
Bottom line
Topical tretinoin has a deep trial record, and its own wrinkle label says it helps fine wrinkles modestly, does not reverse photoaging, irritates skin and must not be used in pregnancy. Use the count to see the record exists, then ask a dermatologist about your skin.
How do I cite this page?
Cite the page and the date its figures were read. Every count here is a count of records matching a published query on the day it was read, so it can move; the method box on this page prints the query so you can re-run it.
APA
Whitepill editorial desk. (2026, November 3). How deep is the trial record for tretinoin, and what do the FDA labels say. Whitepill. https://whitepill.dev/articles/tretinoin-trial-record-and-what-the-fda-labels-say
BibTeX
@online{whitepill_tretinoin_trial_record_and, author = {{Whitepill editorial desk}}, title = {How deep is the trial record for tretinoin, and what do the FDA labels say}, year = {2026}, month = nov, url = {https://whitepill.dev/articles/tretinoin-trial-record-and-what-the-fda-labels-say}, note = {Last modified 2026-11-03}
}
Published 3 November 2026. Last modified 3 November 2026. Where a figure rests on secondary reporting, the page says so; do not present that as a primary source.
What has changed on this page?
new Published. PubMed counts were read on 30 October 2026, and the Renova and Retin-A labels, MedlinePlus and two review abstracts on 3 November 2026.